Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8258905 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2017 | 21 Pages |
Abstract
Dilated cardiomyopathy (DCM) is cardiac disease characterized by increased left ventricular chamber volume and decreased systolic function. DCM patient-specific human induced-pluripotent stem cells-derived cardiomyocytes (DCM-hiPSC-CMs) were generated. We found that uniaxial stretch elicited a cytosolic [Ca2Â +]i rise in hiPSC-CMs. Compared to control-hiPSC-CMs, DCM-hiPSC-CMs displayed a greater magnitude of [Ca2Â +]i responses to the cell stretch of 10-15% elongation in length. This stretch-induced [Ca2Â +]i rise was abolished by removal of extracellular Ca2Â + and markedly attenuated by TRPV4 inhibitors HC-067047 and RN-1734. Application of nifedipine and tranilast also reduced the [Ca2Â +]i response but to a lesser degree. Moreover, the augmented [Ca2Â +]i was decreased by cytochalasin D treatment. Taken together, our study for the first time demonstrated an abnormal TRPV4-related mechanosensitive Ca2Â + signaling in DCM-hiPSC-CMs.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Jun Lu, Yee-Ki Lee, Xinru Ran, Wing-Hon Lai, Ronald A. Li, Wendy Keung, Kennis Tse, Hung-Fat Tse, Xiaoqiang Yao,